AiViva BioPharma, Inc. is a privately owned clinical stage biotech developing novel technologies to address unmet medical needs by transforming existing treatments to create localized, targeted treatment of diseases while limiting systemic exposure. Our core competency includes development of drugs using our proprietary JELâ„¢ Technology in specialty therapeutic areas of Dermatology, Ophthalmology, Urology, and Oncology.